Addex Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $115 | $234 | $153 | $153 |
Gross Profit | 115 | 235 | -1,392 | |
EBITDA | -1,343 | -785 | -2,769 | |
EBIT | -1,455 | -788 | -2,848 | |
Net Income | 12,878 | -3,087 | -2,856 | -2,856 |
Net Change In Cash | 115 | 234 | 153 | 153 |
Free Cash Flow | -2,757 | -2,193 | -624 | -624 |
Cash | 3,787 | 1,627 | 3,865 | 3,865 |
Basic Shares | 97,534 | 97,534 | 125,195 | 95,236 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $1,612 | $1,422 | $2,916 | $3,612 |
Gross Profit | -5,322 | -13,201 | -9,902 | -6,760 |
EBITDA | -10,228 | -20,228 | -14,941 | -12,410 |
EBIT | -10,534 | -20,551 | -15,288 | -12,789 |
Net Income | -10,556 | -20,804 | -15,351 | -12,858 |
Net Change In Cash | 1,612 | 1,422 | 2,916 | 3,612 |
Free Cash Flow | -7,999 | -16,437 | -14,736 | -12,239 |
Cash | 3,865 | 6,957 | 20,484 | 18,695 |
Basic Shares | 74,307 | 45,184 | 34,119 | 26,681 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $10.17 |
2024-03-31 | -$4.05 |
2023-09-30 | -$4.59 |
2023-06-30 | -$0.04 |
